Serum vascular endothelial growth factors C and D as forecast tools for patients with gallbladder carcinoma

详细信息    查看全文

• 作者：Min-Chao Liu ; Lei Jiang ; Hai-Jie Hong ; Ze-Wu Meng ; Qiang Du ; Liang-Yi Zhou…
• 关键词：Gallbladder carcinoma ; Serum VEGF ; C ; Serum VEGF ; D ; Lymph nodes metastases ; Prognosis
• 刊名：Tumor Biology
• 出版年：2015
• 出版时间：August 2015
• 年：2015
• 卷：36
• 期：8
• 页码：6305-6312
• 全文大小：376 KB
• 参考文献：1.Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9-9. doi:10.-322/?caac.-1208 .CrossRef PubMed
  2.Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol. 2014;6:99-09. doi:10.-147/?clep.?s37357 .PubMed Central PubMed
  3.Miller G, Jarnagin WR. Gallbladder carcinoma. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2008;34(3):306-2. doi:10.-016/?j.?ejso.-007.-7.-06 .
  4.Duffy A, Capanu M, Abou-Alfa GK, Huitzil D, Jarnagin W, Fong Y, et al. Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol. 2008;98(7):485-. doi:10.-002/?jso.-1141 .CrossRef PubMed
  5.Cho SY, Kim SH, Park SJ, Han SS, Kim YK, Lee KW, et al. Adjuvant chemoradiation therapy in gallbladder cancer. J Surg Oncol. 2010;102(1):87-3. doi:10.-002/?jso.-1544 .CrossRef PubMed
  6.Makinen T, Veikkola T, Mustjoki S, Karpanen T, Catimel B, Nice EC, et al. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J. 2001;20(17):4762-3. doi:10.-093/?emboj/-0.-7.-762 .PubMed Central CrossRef PubMed
  7.Wang XL, Ai ZS, Fang JP, Tang RY, Chen XM. Expression of vascular endothelial growth factors (VEGF)-A, -C and -D and their prognostic significance and relationship with angio- and lymphangiogenesis in gastric cancer. Zhonghua zhong liu za zhi [Chin J Oncol]. 2008;30(11):837-3.
  8.Onogawa S, Kitadai Y, Tanaka S, Kuwai T, Kimura S, Chayama K. Expression of VEGF-C and VEGF-D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma. Cancer Sci. 2004;95(1):32-.CrossRef PubMed
  9.Jiang L, Chen YL, She FF, Tang NH, Li XJ, Wang XX. Expressions of VEGF-C and VEGF-D and their correlation with lymphangiogenesis and angiogenesis in gallbladder carcinoma. Zhonghua zhong liu za zhi [Chin J Oncol]. 2010;32(3):190-.
  10.Wang T, Deng M, Qiu W, Dong W. Association of serum vascular endothelial growth factor-C and lymphatic vessel density with lymph node metastasis and prognosis of patients with gastric cancer. World J Gastroenterol. 2007;13(12):1794-. discussion 7-8.PubMed Central CrossRef PubMed
  11.Lai CW, Chen KY, Hung CS, Kuo SW, Chang YJ, Lin MT, et al. Serum vascular endothelial growth factor-D levels correlate with cervical lymph node metastases in papillary thyroid carcinoma. Growth Factors. 2011;29(2-):57-2. doi:10.-109/-8977194.-011.-57373 .CrossRef PubMed
  12.Edge SB BD, Compton CC, et al. AJCC Cancer Staging Manual. Springer. 2009;211-7.
  13.Naumnik W, Izycki T, Swidzińska E, Ossolińiska M, Chyczewska E. Serum levels of VEGF-C, VEGF-D, and sVEGF-R2 in patients with lung cancer during chemotherapy. Oncol Res. 2007;16(9):445-1.PubMed
  14.Kozlowski M, Kowalczuk O, Milewski R, Chyczewski L, Niklinski J, Laudański J. Serum vascular endothelial growth factors C and D in patients with oesophageal cancer. Eur J Cardiothorac Surg. 2010;38(3):260-. doi:10.-016/?j.?ejcts.-010.-1.-61 .CrossRef PubMed
  15.Tsirlis T, Kostakis A, Papastratis G, Masselou K, Vlachos I, Papachristodoulou A, et al. Predictive significance of preoperative serum VEGF-C and VEGF-D, independently and combined with Ca19-9, for the presence of malignancy and lymph node metastasis in patients with gastric cancer. J Surg Oncol. 2010;102(6):699-03.CrossRef PubMed
  16.Al-Moundhri M, Al-Shukaili A, Al-Nabhani M, Al-Bahrani B, Burney I, Rizivi A, et al. Measurement of circulating levels of VEGF-A, -C, and -D and their receptors, VEGFR-1 and -2 in gastric adenocarcinoma. World J Gastroenterol. 2008;14(24):3879-3.PubMed Central CrossRef PubMed
  17.George ML, Tutton MG, Janssen F, Arnaout A, Abulafi AM, Eccles SA, et al. VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression. Neoplasia (New York, NY). 2001;3(5):420-.CrossRef
  18.Nakashima T1 KS, Kitoh H, Ozawa H, Okita S, Harada T, Shiraishi K, Ryozawa S, Okita K. Vascular endothelial growth factor-C expression in human gallbladder cancer and its relationship to lymph node metastasis. Int J Mol Med. 2003;11(1):33-.
  19.Schimanski CC, Schlaegel F, Jordan M, Moehler M, Sgourakis G, Drescher DG, et al. VEGF-D correlates with metastatic disease in gastric cancer patients undergoing surgery. World J Surg. 2011;35(5):1010-. doi:10.-007/?s00268-011-1041-7 .CrossRef PubMed
  20.Mitsuhashi A, Suzuka K, Yamazawa K, Matsui H, Seki K, Sekiya S. Serum vascular endothelial growth factor (VEGF) and VEGF-C levels as tumor markers in patients with cervical carcinoma. Cancer. 2005;103(4):724-0. doi:10.-002/?cncr.-0819 .CrossRef PubMed
  21.Rana S, Dutta U, Kochhar R, Rana SV, Gupta R, Pal R, et al. Evaluation of CA 242 as a tumor marker in gallbladder cancer. J Gastrointest Cancer. 2012;43(2):267-1. doi:10.-007/?s12029-011-9288-7 .CrossRef PubMed
  22.Strom BL, Maislin G, West SL, Atkinson B, Herlyn M, Saul S, et al. Serum CEA a
• 作者单位：Min-Chao Liu (1) (2)
  Lei Jiang (1) (2)
  Hai-Jie Hong (1) (2)
  Ze-Wu Meng (1) (2)
  Qiang Du (1) (2)
  Liang-Yi Zhou (1) (2)
  Fei-Fei She (2) (3)
  Yan-Ling Chen (1) (2)
  
  1. Department of Hepatobiliary Surgery, the Affiliated Union Hospital of Fujian Medical University, 29 Xinquan Road, Fuzhou, Fujian, 350001, People’s Republic of China
  2. Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, Fujian, 350108, People’s Republic of China
  3. Key Laboratory of Tumor Microbiology, School of Basic Medical Sciences, Fujian Medical University, 1 Xueyuan Road, Fuzhou, Fujian, 350108, People’s Republic of China
  
• 刊物主题：Cancer Research;
• 出版者：Springer Netherlands
• ISSN：1423-0380

文摘

Gallbladder carcinoma (GBC) is the most common cancer of the biliary tract. Lymph node metastasis (LNM) is the major diffusion route of GBC and is a prognosis factor. The aim of study was to assess the potential of the serum VEGF-C and VEGF-D (sVEGF-C/D) levels to predict the presence of LNM and the survival of GBC patients. The preoperative sVEGF-C/D levels of 31 patients with GBC, 10 patients with cholesterol polyps, and 10 healthy volunteers were measured by enzyme-linked immunoadsorbent assay (ELISA). The sVEGF-C/D levels of patients with GBC were significantly higher than those of people with healthy gallbladders (p-lt;-.001 and p--.001, respectively) and cholesterol polyp (p--.032 and p--.004, respectively). In GBC, the sVEGF-C levels were associated with LNM (p--.011), distant metastasis (p--.018), and stage (p--.045), but the sVEGF-D levels had a significant association with the tumor depth (p--.001), LNM (p--.001), distant metastasis (p--.047), and stage (p--.002). The sVEGF-C/D diagnostic values for the presence of GBC were sensitivity of 71.0 and 74.2 % and specificity of 80.0 and 85.0 %, respectively. With respect to the diagnosis of LNM, the diagnostic values of sVEGF-C/D were as follows: sensitivity 81.2 and 87.5 % and specificity 73.3 and 80.0 %, respectively. The mean survival time with high sVEGF-C was significantly shorter than that with low sVEGF-C (p-lt;-.001), which was also true for low sVEGF-D (p--.032). The preoperative sVEGF-C/D levels might be reliable biomarkers for the presence of disease and LNM in patients with GBC. The sVEGF-C/D levels may be prognosis factors that can predict a poor outcome for GBC patients. Keywords Gallbladder carcinoma Serum VEGF-C Serum VEGF-D Lymph nodes metastases Prognosis